NEWS & RESOURCES
(주)엠디엑스케이는 고객의 연구 목적에 적합한 기술과 서비스를 제공합니다.
- NEWS & RESOURCES
 |
Cell Line Development : Best production ..Best production cell lineswith >99% monoclonality assuranceRapid Workflow8-12 주 동안 진행하며 어려움이 많았던,일반적으로 사용.. 2020-09-03 |
|
|---|---|---|
 |
How Pediatric Immune Systems Empower Can..How Pediatric Immune Systems Empower Cancer ImmunotherapyWhy children’s T cells helped chimeric antigen recept.. 2020-05-04 |
|
 |
Panel Discussion: Can Humanity Build a G..Can Humanity Build a Global Antibody Defense Barrier Against Future Pandemics ?항체는 COVID-19와의 투쟁에서 중심에 있습니다.현재.. 2020-05-04 |
|
 |
Rapid Discovery of Functional Antibodies..Rapid Discovery of Functional Antibodies for SARS-CoV-2 Using the Beacon SystemSARS-CoV-2에 대응하는 수백 가지의 독특한 항체.. 2020-05-04 |
|
 |
Accelerating the Antibody Discovery Work..Accelerating the Antibody Discovery Workflow in the Modern Therapeutic Landscape2020년 4월 15일 오전 1시 (한국시간) Host.. 2020-04-13 |
|
Most viewed
 |
PUBLICATION
Long-read human geno..
419 VIEWS
|
|---|---|
 |
PUBLICATION
Telomere-to telomre ..
389 VIEWS
|
 |
PUBLICATION
Rapid isolation and ..
380 VIEWS
|
